Podcast TCTMD Talking Points Stent Wars Dr. C. Michael Gibson talks with Dr. Roxana Mehran about head-to-head trials of new DES.
Podcast TCTMD Talking Points FAME 2: 3-Year Clinical and Cost-Effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease William Fearon sits down with C. Michael Gibson to discuss the 3 year results from FAME 2.
Podcast TCTMD Talking Points ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease The ABSORB trials have grabbed the limelight for years. Now C. Michael Gibson hears about the 3 year ABSORB III results from Stephen G. Ellis.
Podcast TCTMD Talking Points REVASC: A Randomized Trial to Assess Recovery of Left Ventricular Function After PCI of Coronary Artery Chronic Total Occlusions C. Michael Gibson gets the details on REVASC from Kambis Mashayekhi.
Podcast TCTMD Talking Points Women in Cardiology: Breaking the Glass Ceiling What will it take for see equal numbers of men and women in the profession, making equal pay? C. Michael Gibson sits down with Pamela Douglas.
Podcast TCTMD Talking Points Quality of Life After PCI vs CABG in Left Main CAD: EXCEL C. Michael Gibson gets the details of the new QoL analysis of EXCEL from Suzanne J. Baron.
Podcast TCTMD Talking Points PLATINUM DIVERSITY: Increased Risk of Cardiac Events After PCI in Minority Women C. Michael Gibson discusses clinical, social, and behavioral predictors of increased events in this group with Roxana Mehran and Wayne Batchelor.
Podcast TCTMD Talking Points DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis Drug eluting balloons have a role to play in the treatment of in-stent restenosis, Jose P. S. Henriques tells C. Michael Gibson.
Podcast TCTMD Talking Points INTREPID: 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation Early results with a new device being developed for transcatheter MV replacement are promising, Paul Sorajja tells C. Michael Gibson.
Podcast TCTMD Talking Points DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI C. Michael Gibson gets the details from DAPT-STEMI from Elvin Kedhi.